News: Hospira Inc (HSP.N)

HSP.N on New York Stock Exchange

35.08USD
24 May 2013
Price Change (% chg)

$-0.10 (-0.28%)
Prev Close
$35.18
Open
$34.97
Day's High
$35.26
Day's Low
$34.72
Volume
147,967
Avg. Vol
332,878
52-wk High
$37.78
52-wk Low
$28.63

Search Stocks
Select another date:

Mon, May 20 2013

U.S. court ruling favors Cubist in patent case versus Hospira

- A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc .

Continue Reading

U.S. court ruling favors Cubist in patent case vs Hospira

May 20 - A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc.

FDA flags new concerns on Hospira's Rocky Mount plant

- Hospira Inc said U.S. health regulators raised fresh concerns about the injectable-drugs maker's troubled Rocky Mount, North Carolina manufacturing plant - one of its largest production facilities.

Hospira withdraws outlook on FDA import ban, shares fall

- Injectable-drugs maker Hospira Inc withdrew the 2013 profit and revenue outlook it gave on Wednesday after the U.S. health regulator imposed an import ban on some of its products.

Hospira gets FDA notice over medical device problems

- Hospira Inc, a hospital products maker that has grappled with regulatory issues at manufacturing plants for the past 18 months, said it had received a notice over the quality of its medical devices from the U.S. Food and Drug Administration.

UPDATE 3-Hospira gets FDA notice over medical device problems

* Expects 2013 sales up 1 pct to 3 pct, adjusted diluted eps of $2.05-$2.20

Hospira swings to profit in fourth quarter as sales rise

Feb 13 - Injectable drug provider Hospira Inc on Wednesday reported a profit for the fourth quarter versus a year-earlier loss as its sales increased more than 8 percent.

UPDATE 1-Hospira recalls electrolyte solution after mold found

Jan 28 - Hospira Inc is recalling one lot of an intravenous electrolyte solution after the discovery of the presence of a substance that was consistent with mold, U.S. health regulators said on Monday.

Hospira recalls one lot of electrolyte solution after mold found

- Hospira Inc is recalling one lot of an intravenous electrolyte solution after the discovery of the presence of a substance that was consistent with mold, U.S. health regulators said on Monday.

Hospira recalls one lot of electrolyte solution after mold found

Jan 28 - Hospira Inc is recalling one lot of an intravenous electrolyte solution after the discovery of the presence of a substance that was consistent with mold, U.S. health regulators said on Monday.

Select another date:

Market Views

» More HSP.N Market Views

Press Releases

Search Stocks